New hair loss gel shows promise in early trial

NCT ID NCT06393452

First seen Jan 11, 2026 · Last updated Apr 30, 2026 · Updated 13 times

Summary

This study tested a gel called PP405 for safety and early signs of hair regrowth in 78 adults with male or female pattern baldness. Participants used the gel daily for up to 3 months. The main goal was to check for side effects and how the body processes the drug. This is an early-stage trial, so more research is needed to know if it really works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • California Dermatology & Clinical Research Institute

    Encinitas, California, 92024, United States

  • Clinical Trials Research Institute

    Thousand Oaks, California, 91320, United States

  • Dawes Fretzin Clinical Research Group, LLC

    Indianapolis, Indiana, 46250, United States

  • DermResearch

    Austin, Texas, 78759, United States

  • Jordan Valley Dermatology Center

    South Jordan, Utah, 84095, United States

  • Minnesota Clinical Study Center

    New Brighton, Minnesota, 55112, United States

  • Stride Clinical Research LLC

    Sugar Land, Texas, 77479, United States

  • Virginia Clinical Research, Inc.

    Norfolk, Virginia, 23502, United States

Conditions

Explore the condition pages connected to this study.